PCD

DRUG4 trials

Sponsors

Temple University, Ohio State University Comprehensive Cancer Center, Institut Curie, National University Hospital, Singapore

Conditions

Bone MetastasesFirst RelapseMultiple MyelomaMusculoskeletal CancerRelapse Multiple MyelomaSoft Tissue SarcomaThromboembolismType 2 Diabetes

Phase 2

A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)

CompletedNCT02244125

Institut CurieFirst Relapse, Multiple Myeloma

Start: 2014-04-14End: 2023-05-29Updated: 2025-11-24

Phase 3

Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma

National University Hospital, SingaporeRelapse Multiple Myeloma

Start: 2017-09-13End: 2022-06-01Target: 120Updated: 2017-11-06

Unknown Phase

Pilot Study to Assess Pre-packaged, Portion-controlled Meal Plan on Weight Loss

CompletedNCT00593476

Temple UniversityType 2 Diabetes

Start: 2007-03-31End: 2009-03-31Updated: 2013-07-01

Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology

CompletedNCT01696760

Ohio State University Comprehensive Cancer CenterBone Metastases, Musculoskeletal Cancer, Soft Tissue Sarcoma +1

Start: 2010-10-31End: 2012-12-31Updated: 2018-12-05

Related Papers

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).

2025-10-06

Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial

Blood2020-11-04118 citations

Phase 3 Study of Pomalidomide with Cyclophosphamide and Dexamethasone Versus Pomalidomide and Dexamethasone in Asian Patients with Relapsed/Refractory Myeloma (RRMM) - Interim Analysis of a Trial By the Asian Myeloma Network (AMN)

Blood2020-11-041 citations

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma

Blood2018-10-0364 citations

A Multicenter Open Label Phase II Study of Pomalidomide, Cyclophosphamide and Dexamethasone in Relapse Multiple Myeloma Patients Initially Treated with Lenalidomide, Bortezomib and Dexamethasone

Blood2017-12-075 citations